A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

ONO-5129

Trial Locations (67)

11021

DiGiovanna Family Care Center, Great Neck

United Physicians Group - Endocrine Division, Great Neck

11501

Winthrop University Hospital, Mineola

13326

Bassett Healthcare, Cooperstown

15238

Research Endeavors, Pittsburgh

16602

Keystone Clinical Solutions, Altoona

19083

Southeastern PA Medical Institute, Havertown

19107

Thomas Jefferson University Div of Endocrinology, Philadelphia

19152

Founders Medical Practice, Philadelphia

19446

Greenand Seidner Family Practice, Lansdale

19713

Institute Diabetes and Metabolic Disease, Newark

21075

Centennial Medical Group, Elkridge

21237

Franklin Square Hospital Center, Baltimore

25304

Hyperion Clinical Trials, Inc., Charleston

29303

Spartanburg Medical Research, Spartanburg

29681

Hillcrest Clinical Research LLC, Simpsonville

30342

Executive Health and Research Associates, Inc., Atlanta

32117

Century Clinical Research, Inc, Holly Hill

33445

Personal Physician Care, Delray Beach

33755

Alliance Medical Reserach Group, Inc., Clearwater

33770

Innovative Research of West Florida, Largo

34239

Cardiovascular Center of Sarasota, Sarasota

35040

Med Search, LLC, Calera

35209

Apex Clinical Trials, Inc., Birmingham

35242

Greystone Medical Research, LLC, Birmingham

35801

Medical Affiliated Research Center, Huntsville

43537

Fallen Timbers Internal Medicine LLC, Maumee

45252

New Horizons Clinical Research, Cincinnati

45429

Wells Institute for Health Awareness, Kettering

48602

Synergy Medical Education Alliance, Saginaw

49601

Professional Clinical Reserach -Great Lakes Family Care, Cadillac

59701

Mercury Street Medical, Butte

60607

Cedar-Crosse Research Center, Chicago

60634

Chicago Research Center, Inc., Chicago

63108

Medex Healthcare Research, Inc, St Louis

66216

Heart of America Research, Shawnee

70809

Dolby Research, LLC, Baton Rouge

73103

COR Clinical Reserch, LLC, Oklahoma City

75007

John Joseph, MD PA, Carrollton

75093

Professional for Clinical Research, Plano

Research Across America, Plano

75235

Renaissance Clinical Research, Dallas

77024

MCA Research, Houston

77074

Southwest Houston Research, LTD, Houston

78216

Benjamin Garwood Research, San Antonio

78217

WellMed at Northern Hills, San Antonio

78229

Diabetes and Glandular Disease Research Associates, San Antonio

78237

Diabetes and Glandular Disease - Westside office, San Antonio

80120

Arapahoe Internal Medicine, Littleton

83702

Capital City Family Medicine, Boise

Orthopedic Health Care Clinic, Boise

Sonora Clinical Research, Boise

85201

Clinic of Physicians and Surgeons, Mesa

85206

Horizon Clinical Research Associates, Mesa

85635

Cochise Clinical Research, Sierra Vista

89048

Specialty Medical Center, Pahrump

91978

Encompass Clinical Research, Spring Valley

92084

Quality Care Medical Center, Vista

92610

Family Medical Center, Foothill Ranch

92691

Prime-Care Clinical Research, Mission Viejo

92739

Covance Clinical Research Unit, Inc, Portland

92780

Orange County Research Center, Tustin

93305

Sagebrush Medical Plaza, Department of Family Medicine, Bakersfield

97232

Michael A. Azorr, M.D., Portland

97504

Cllinical Research Consultants, Medford

98405

Liberty Research Center, Tacoma

04401

Acadia Clinical Research, LLC, Bangor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ono Pharma USA Inc

INDUSTRY

NCT00212641 - A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter